NYSE · CVSA

Covista Inc.

$115.84 +$0.71 (+0.62%) 1D After hours

Key Metrics

$3.92B
Market cap
16.74×
P/E · TTM
$1.91B
Revenue · TTM
$234.06M
Net income
EPS · TTM $6.50
Dividend yield
Free cash flow $336.28M
Beta · 1Y
EBITDA · TTM $367.11M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 15
    The stock moved -12.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 15
  • May 8
    The stock moved +14.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 8

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$3.92B
Enterprise value$4.27B
Shares outstanding34.0M
52-wk range$94.11 – $135.96
Avg volume · 20D342.4K
Net cash −$352.49M
Book value / share$37.86
IndustryServices-Educational Services
ExchangeNYSE
About Covista Inc.
IPO dateJun 21, 1991
Employees4996

Covista Inc is an American healthcare educator, serving more than 97,000 students and supported by a community of alumni across five accredited institutions. Through personalized, tech-enabled education powered by faculty and colleagues, it expands access to healthcare careers and addresses the U.S.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E16.74
P/S2.05
P/FCF11.65
EV/EBITDA11.63
EV/Sales2.24
Graham №$74.39

Profitability

Gross
Operating 17.0%
Net 12.3%
FCF 17.6%
ROE / ROIC 17.1% · 14.5%

Financial Health

Current ratio0.70
Quick ratio
Debt / equity0.37
Debt / EBITDA 1.36
Net cash −$352.49M
Working capital−$176.69M

Cash Flow · TTM

Operating CF $406.15M
Capex −$69.87M
Free cash flow $336.28M
Buybacks $306.56M
Dividends paid
Shareholder yield 7.8%

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

4.2
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$74.39 vs $115.84
Trades 1.6× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings